Cargando…
Tumor-suppressive circRHOBTB3 is excreted out of cells via exosome to sustain colorectal cancer cell fitness
BACKGROUND & AIMS: To clarify the biological roles, circularization process and secretion pathway of circRHOBTB3 in colorectal cancer (CRC) progression. METHODS: We performed a comprehensive analysis of circRNA levels in serum exosomes from multiple types of cancer patients in public databases a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832727/ https://www.ncbi.nlm.nih.gov/pubmed/35148775 http://dx.doi.org/10.1186/s12943-022-01511-1 |
_version_ | 1784648779166646272 |
---|---|
author | Chen, Chaoyi Yu, Hongfei Han, Fengyan Lai, Xuan Ye, Kehong Lei, Siqin Mai, Minglang Lai, Maode Zhang, Honghe |
author_facet | Chen, Chaoyi Yu, Hongfei Han, Fengyan Lai, Xuan Ye, Kehong Lei, Siqin Mai, Minglang Lai, Maode Zhang, Honghe |
author_sort | Chen, Chaoyi |
collection | PubMed |
description | BACKGROUND & AIMS: To clarify the biological roles, circularization process and secretion pathway of circRHOBTB3 in colorectal cancer (CRC) progression. METHODS: We performed a comprehensive analysis of circRNA levels in serum exosomes from multiple types of cancer patients in public databases and verified the higher level of circRHOBTB3 in CRC sera versus healthy donors by RT-qPCR. Then, the function of circRHOBTB3 in CRC was investigated in vitro and in vivo. RNA-seq and RNA pull-down assays together with mass spectrometry identified the downstream signals and the binding proteins of circRHOBTB3. Finally, Antisense oligonucleotides (ASOs) were designed to target circularization and secretion elements of circRHOBTB3 for CRC therapy. RESULTS: circRHOBTB3 levels were increased in the sera but was downregulated in tissue samples in CRC, and the downregulation was associated with poor prognosis. Furthermore, circRHOBTB3 acts a tumor-suppressive circRNA by repressing metabolic pathways, intracellular ROS production in CRC. Several key elements were discovered to regulate circRHOBTB3 circularization and exosomal secretion. Moreover, SNF8 was identified that sorts circRHOBTB3 into exosomes. Interestingly, we found that CRC cells could actively secrete more circRHOBTB3 than normal cells. According to the sequence of regulatory elements for circularization and exosomal secretion, we designed and synthesized ASOs, which increased circRHOBTB3 expression and blocked circRHOBTB3 exosomal secretion. More importantly, ASOs could inhibit CRC growth and metastasis in vitro and in vivo. CONCLUSIONS: circRHOBTB3 plays a tumor-suppressive role in CRC and has to be excreted out of cells to sustain cancer cell fitness. ASOs targeting regulatory elements for circularization and exosomal secretion will become a novel antitumor strategy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12943-022-01511-1. |
format | Online Article Text |
id | pubmed-8832727 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88327272022-02-11 Tumor-suppressive circRHOBTB3 is excreted out of cells via exosome to sustain colorectal cancer cell fitness Chen, Chaoyi Yu, Hongfei Han, Fengyan Lai, Xuan Ye, Kehong Lei, Siqin Mai, Minglang Lai, Maode Zhang, Honghe Mol Cancer Research BACKGROUND & AIMS: To clarify the biological roles, circularization process and secretion pathway of circRHOBTB3 in colorectal cancer (CRC) progression. METHODS: We performed a comprehensive analysis of circRNA levels in serum exosomes from multiple types of cancer patients in public databases and verified the higher level of circRHOBTB3 in CRC sera versus healthy donors by RT-qPCR. Then, the function of circRHOBTB3 in CRC was investigated in vitro and in vivo. RNA-seq and RNA pull-down assays together with mass spectrometry identified the downstream signals and the binding proteins of circRHOBTB3. Finally, Antisense oligonucleotides (ASOs) were designed to target circularization and secretion elements of circRHOBTB3 for CRC therapy. RESULTS: circRHOBTB3 levels were increased in the sera but was downregulated in tissue samples in CRC, and the downregulation was associated with poor prognosis. Furthermore, circRHOBTB3 acts a tumor-suppressive circRNA by repressing metabolic pathways, intracellular ROS production in CRC. Several key elements were discovered to regulate circRHOBTB3 circularization and exosomal secretion. Moreover, SNF8 was identified that sorts circRHOBTB3 into exosomes. Interestingly, we found that CRC cells could actively secrete more circRHOBTB3 than normal cells. According to the sequence of regulatory elements for circularization and exosomal secretion, we designed and synthesized ASOs, which increased circRHOBTB3 expression and blocked circRHOBTB3 exosomal secretion. More importantly, ASOs could inhibit CRC growth and metastasis in vitro and in vivo. CONCLUSIONS: circRHOBTB3 plays a tumor-suppressive role in CRC and has to be excreted out of cells to sustain cancer cell fitness. ASOs targeting regulatory elements for circularization and exosomal secretion will become a novel antitumor strategy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12943-022-01511-1. BioMed Central 2022-02-11 /pmc/articles/PMC8832727/ /pubmed/35148775 http://dx.doi.org/10.1186/s12943-022-01511-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Chen, Chaoyi Yu, Hongfei Han, Fengyan Lai, Xuan Ye, Kehong Lei, Siqin Mai, Minglang Lai, Maode Zhang, Honghe Tumor-suppressive circRHOBTB3 is excreted out of cells via exosome to sustain colorectal cancer cell fitness |
title | Tumor-suppressive circRHOBTB3 is excreted out of cells via exosome to sustain colorectal cancer cell fitness |
title_full | Tumor-suppressive circRHOBTB3 is excreted out of cells via exosome to sustain colorectal cancer cell fitness |
title_fullStr | Tumor-suppressive circRHOBTB3 is excreted out of cells via exosome to sustain colorectal cancer cell fitness |
title_full_unstemmed | Tumor-suppressive circRHOBTB3 is excreted out of cells via exosome to sustain colorectal cancer cell fitness |
title_short | Tumor-suppressive circRHOBTB3 is excreted out of cells via exosome to sustain colorectal cancer cell fitness |
title_sort | tumor-suppressive circrhobtb3 is excreted out of cells via exosome to sustain colorectal cancer cell fitness |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832727/ https://www.ncbi.nlm.nih.gov/pubmed/35148775 http://dx.doi.org/10.1186/s12943-022-01511-1 |
work_keys_str_mv | AT chenchaoyi tumorsuppressivecircrhobtb3isexcretedoutofcellsviaexosometosustaincolorectalcancercellfitness AT yuhongfei tumorsuppressivecircrhobtb3isexcretedoutofcellsviaexosometosustaincolorectalcancercellfitness AT hanfengyan tumorsuppressivecircrhobtb3isexcretedoutofcellsviaexosometosustaincolorectalcancercellfitness AT laixuan tumorsuppressivecircrhobtb3isexcretedoutofcellsviaexosometosustaincolorectalcancercellfitness AT yekehong tumorsuppressivecircrhobtb3isexcretedoutofcellsviaexosometosustaincolorectalcancercellfitness AT leisiqin tumorsuppressivecircrhobtb3isexcretedoutofcellsviaexosometosustaincolorectalcancercellfitness AT maiminglang tumorsuppressivecircrhobtb3isexcretedoutofcellsviaexosometosustaincolorectalcancercellfitness AT laimaode tumorsuppressivecircrhobtb3isexcretedoutofcellsviaexosometosustaincolorectalcancercellfitness AT zhanghonghe tumorsuppressivecircrhobtb3isexcretedoutofcellsviaexosometosustaincolorectalcancercellfitness |